# Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

> **NCT00882687** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 60 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Lifitegrast
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00882687
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-24
- **Primary completion:** 2009-05-10
- **Final completion:** 2009-05-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882687, "Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00882687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*